Xcout Intel
PerciseDx, Inc.
PreciseDx, Inc. provides an AI-powered platform called OncoIntelligence and its specific product, PreciseBreast, to analyze tissue samples and determine breast cancer recurrence risk. The company serves oncologists, surgeons, pathologists, payors, and patients by offering objective risk stratification and phenotype insights within hours.
Subscribe to see PerciseDx, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PerciseDx, Inc. at a glance
PerciseDx, Inc. is a healthcare ai company headquartered in United States. Its most recent funding round, Series B, raised $20.7M in August 2024.
PerciseDx, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $20.7M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
PerciseDx, Inc. competitors
A few of PerciseDx, Inc.'s closest competitors — see the full list of competitors and alternatives →
Mindpeak is an artificial intelligence company based in Hamburg, Germany, that builds AI solutions for precision medicine and pathology.
Imagene AI is a pioneering company in the field of AI-driven medical diagnostics, leveraging deep learning to analyze biological samples.
Entelai develops artificial intelligence solutions for clinical diagnosis, aimed at healthcare professionals, medical institutions, and patients. Its technology is designed to improve diagnostic accuracy, optimize medical workflows, and facilitate online medical prescriptions and studies.
Quibim provides an AI-powered, cloud-based platform and software-as-a-medical-device products that extract radiomics and imaging biomarkers from medical scans. The company serves healthcare providers and life sciences organizations by offering automated image analysis tools for organs such as the prostate, brain, liver, breast, and lungs to improve diagnostics, clinical research, and drug development.
Kheiron Medical Technologies is a healthcare AI company that develops machine-learning software to assist with medical imaging, particularly breast cancer screening. Its products are used by radiologists and healthcare providers to help detect breast cancer and improve screening workflows.
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics using its Polaris discovery platform. The company is headquartered in Berlin, Germany.
Get PerciseDx, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on PerciseDx, Inc. in Xcout Intel
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access